FDA authorizes use of new device to treat esophageal birth defect in babies

By Newsroom America Feeds at 12 May 2017

The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm558241.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL